Literature DB >> 33394356

Current status of robotic gastrectomy for gastric cancer: comparison with laparoscopic gastrectomy.

Yoo Min Kim1, Woo Jin Hyung2.   

Abstract

Robotic systems were developed to overcome limitations of laparoscopic surgery with its mechanical advantages. Along with the technical advances, robotic gastrectomy for gastric cancer is increasing. However, the evidence regarding safety and efficacy for robotic gastrectomy for gastric cancer is not mature yet. Although studies are limited, it is evident that robotic gastrectomy has a longer operation and less blood loss compared with laparoscopic gastrectomy. Studies revealed long-term oncological outcomes after robotic gastrectomy was comparable to those after laparoscopic gastrectomy. Taken together, robotic gastrectomy with systemic lymph node dissection is suggested as a safe procedure with equivalent short- and long-term oncologic outcomes to either laparoscopic or open gastrectomy for the surgical treatment of gastric cancer. However, high cost is the most significant barrier to justify robotic surgery as a routine and standard treatment for patients with gastric cancer. In the meanwhile, robotic surgery will be expansively used as long as technologic developments continue.

Entities:  

Keywords:  Gastric cancer; Oncologic outcomes; Operative outcomes; Robotic gastrectomy

Year:  2021        PMID: 33394356     DOI: 10.1007/s13304-020-00958-5

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  72 in total

1.  Learning curve of laparoscopy-assisted distal gastrectomy with systemic lymphadenectomy for early gastric cancer.

Authors:  Min-Chan Kim; Ghap-Joong Jung; Hyung-Ho Kim
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

2.  Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial.

Authors:  Yanfeng Hu; Changming Huang; Yihong Sun; Xiangqian Su; Hui Cao; Jiankun Hu; Yingwei Xue; Jian Suo; Kaixiong Tao; Xianli He; Hongbo Wei; Mingang Ying; Weiguo Hu; Xiaohui Du; Pingyan Chen; Hao Liu; Chaohui Zheng; Fenglin Liu; Jiang Yu; Ziyu Li; Gang Zhao; Xinzu Chen; Kuan Wang; Ping Li; Jiadi Xing; Guoxin Li
Journal:  J Clin Oncol       Date:  2016-02-22       Impact factor: 44.544

3.  The learning curve associated with laparoscopic total gastrectomy.

Authors:  Do Hyun Jung; Sang-Yong Son; Young Suk Park; Dong Joon Shin; Hye Seong Ahn; Sang-Hoon Ahn; Do Joong Park; Hyung-Ho Kim
Journal:  Gastric Cancer       Date:  2014-12-07       Impact factor: 7.370

4.  Risk factors and learning curve associated with postoperative morbidity of laparoscopic total gastrectomy for gastric carcinoma.

Authors:  Oh Jeong; Seong Yeop Ryu; Won Yong Choi; Zhengri Piao; Young Kyu Park
Journal:  Ann Surg Oncol       Date:  2014-04-01       Impact factor: 5.344

Review 5.  Minimally invasive approaches for early gastric cancer in East Asia: current status and future perspective.

Authors:  Takahiro Kinoshita
Journal:  Transl Gastroenterol Hepatol       Date:  2020-04-05

Review 6.  Robotic versus laparoscopic surgery for gastric cancer: an overview of systematic reviews with quality assessment of current evidence.

Authors:  Nobuaki Hoshino; Katsuhiro Murakami; Koya Hida; Shigeo Hisamori; Shigeru Tsunoda; Kazutaka Obama; Yoshiharu Sakai
Journal:  Updates Surg       Date:  2020-05-15

7.  Multidimensional learning curve in laparoscopy-assisted gastrectomy for early gastric cancer.

Authors:  Sung-Ho Jin; Do-Yoon Kim; Hong Kim; In Ho Jeong; Myung-Wook Kim; Yong Kwan Cho; Sang-Uk Han
Journal:  Surg Endosc       Date:  2006-09-06       Impact factor: 4.584

Review 8.  Laparoscopic gastric cancer surgery: Current evidence and future perspectives.

Authors:  Taeil Son; Woo Jin Hyung
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

9.  Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial.

Authors:  Hitoshi Katai; Junki Mizusawa; Hiroshi Katayama; Shinji Morita; Takanobu Yamada; Etsuro Bando; Seiji Ito; Masakazu Takagi; Akinori Takagane; Shin Teshima; Keisuke Koeda; Souya Nunobe; Takaki Yoshikawa; Masanori Terashima; Mitsuru Sasako
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-11-19

10.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

View more
  4 in total

1.  Analysis of Opioid Use in Patients Undergoing Open Versus Robotic Gastrectomy.

Authors:  Yuki Hirata; Russell G Witt; Laura R Prakash; Elsa M Arvide; Kristen A Robinson; Vijaya Gottumukkala; Ching-Wei D Tzeng; Paul Mansfield; Brian D Badgwell; Naruhiko Ikoma
Journal:  Ann Surg Oncol       Date:  2022-05-04       Impact factor: 4.339

Review 2.  Robotic versus Laparoscopic Gastrectomy for Gastric Cancer: An Updated Systematic Review.

Authors:  Maurizio Zizzo; Magda Zanelli; Francesca Sanguedolce; Federica Torricelli; Andrea Morini; David Tumiati; Federica Mereu; Antonia Lavinia Zuliani; Andrea Palicelli; Stefano Ascani; Alessandro Giunta
Journal:  Medicina (Kaunas)       Date:  2022-06-20       Impact factor: 2.948

Review 3.  The Impact of Perioperative Events on Cancer Recurrence and Metastasis in Patients after Radical Gastrectomy: A Review.

Authors:  Xing Zhi; Xiaohong Kuang; Jian Li
Journal:  Cancers (Basel)       Date:  2022-07-19       Impact factor: 6.575

4.  Surgical and oncological outcomes of robotic- versus laparoscopic-assisted distal gastrectomy with D2 lymphadenectomy for advanced gastric cancer: a propensity score‑matched analysis of 1164 patients.

Authors:  Gengmei Gao; Hualin Liao; Qunguang Jiang; Dongning Liu; Taiyuan Li
Journal:  World J Surg Oncol       Date:  2022-09-28       Impact factor: 3.253

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.